Company Profiles

driven by the PitchBook Platform

PhaseBio Pharmaceuticals

Description

Developer of biopharmaceuticals for metabolic and specialty cardiopulmonary disorders. The company has developed once-weekly insulin for type 2 diabetes and once-weekly Vasoactive Intestinal Peptide for heart failure and cardiomyopahty in Duchenne and Becker muscular dystrophy.

2002

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$40M

Latest Deal Amount

$105M

Total Amount Raised

Description

Developer of biopharmaceuticals for metabolic and specialty cardiopulmonary disorders. The company has developed once-weekly insulin for type 2 diabetes and once-weekly Vasoactive Intestinal Peptide for heart failure and cardiomyopahty in Duchenne and Becker muscular dystrophy.

Website:

www.phasebio.com

Formerly Known As

Phase Bioscience

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

1 Great Valley Parkway Suite 30 Malvern, PA 19355United States +1 (610) 981-6500
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore PhaseBio Pharmaceuticals's full profile, request a free trial.

PhaseBio Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

PhaseBio Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

PhaseBio Pharmaceuticals Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Astellas Venture ManagementCorporate Venture CapitalMinority000 0000000 0000
AstraZenecaCorporationMinority000 0000000 0000
Catalysta PartnersVenture CapitalMinority000 0000000 0000
Fletcher Spaght VenturesVenture CapitalMinority000 0000000 0000
Hatteras Venture PartnersVenture CapitalMinority000 0000000 0000
Astellas Venture Management Corporate Venture Capital
AstraZeneca Corporation
Catalysta Partners Venture Capital
Fletcher Spaght Ventures Venture Capital
Hatteras Venture Partners Venture Capital

PhaseBio Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Jonathan MowChief Executive Officer & Board Member
John SharpChief Financial Officer
Susan ArnoldVice President of Preclinical and Assay Development
Jim Ballance Ph.DVice President, Scientific Affairs
John Lee Ph.DChief Medical Officer
Jonathan Mow Chief Executive Officer & Board Member
John Sharp Chief Financial Officer
Susan Arnold Vice President of Preclinical and Assay Development
Jim Ballance Ph.D Vice President, Scientific Affairs
John Lee Ph.D Chief Medical Officer

PhaseBio Pharmaceuticals Board Members (9)

NameRepresentingRoleSinceContact
Info
Ashutosh Chilkoti Ph.DSelfCo-Founder & Board Member000 0000
Asish Xavier Ph.DJohnson & Johnson InnovationVice President, Venture Investments000 0000
Donald DwyerAstraZenecaSenior Director, Licensing & Business Development000 0000
Guy Fish MDFletcher Spaght VenturesVice President000 0000
Jonathan MowPhaseBio PharmaceuticalsChief Executive Officer & Board Member000 0000
Ashutosh Chilkoti Ph.D Co-Founder & Board Member Self
Asish Xavier Ph.D Vice President, Venture Investments Johnson & Johnson Innovation
Donald Dwyer Senior Director, Licensing & Business Development AstraZeneca
Guy Fish MD Vice President Fletcher Spaght Ventures
Jonathan Mow Chief Executive Officer & Board Member PhaseBio Pharmaceuticals
Request full access to PitchBook